These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

375 related items for PubMed ID: 9096324

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Binding areas of urokinase-type plasminogen activator-plasminogen activator inhibitor-1 complex for endocytosis receptors of the low-density lipoprotein receptor family, determined by site-directed mutagenesis.
    Skeldal S, Larsen JV, Pedersen KE, Petersen HH, Egelund R, Christensen A, Jensen JK, Gliemann J, Andreasen PA.
    FEBS J; 2006 Nov; 273(22):5143-59. PubMed ID: 17042782
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The variable region-1 from tissue-type plasminogen activator confers specificity for plasminogen activator inhibitor-1 to thrombin by facilitating catalysis: release of a kinetic block by a heterologous protein surface loop.
    Dekker RJ, Eichinger A, Stoop AA, Bode W, Pannekoek H, Horrevoets AJ.
    J Mol Biol; 1999 Oct 29; 293(3):613-27. PubMed ID: 10543954
    [Abstract] [Full Text] [Related]

  • 10. Expressions of urokinase-type plasminogen activator, its receptor and plasminogen activator inhibitor-1 in gastric cancer cells and effects of Helicobacter pylori.
    Iwamoto J, Mizokami Y, Takahashi K, Nakajima K, Ohtsubo T, Miura S, Narasaka T, Takeyama H, Omata T, Shimokobe K, Ito M, Takehara H, Matsuoka T.
    Scand J Gastroenterol; 2005 Jul 29; 40(7):783-93. PubMed ID: 16109653
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Binding of urokinase to plasminogen activator inhibitor type-1 mediates cell adhesion and spreading.
    Planus E, Barlovatz-Meimon G, Rogers RA, Bonavaud S, Ingber DE, Wang N.
    J Cell Sci; 1997 May 29; 110 ( Pt 9)():1091-8. PubMed ID: 9175705
    [Abstract] [Full Text] [Related]

  • 13. Distal hinge of plasminogen activator inhibitor-1 involves its latency transition and specificities toward serine proteases.
    Wang Q, Shaltiel S.
    BMC Biochem; 2003 Jul 08; 4():5. PubMed ID: 12848892
    [Abstract] [Full Text] [Related]

  • 14. Urokinase-type plasminogen activator/type-2 plasminogen-activator inhibitor complexes are not internalized upon binding to the urokinase-type-plasminogen-activator receptor in THP-1 cells. Interaction of urokinase-type plasminogen activator/type-2 plasminogen-activator inhibitor complexes with the cell surface.
    Ragno P, Montuori N, Rossi G.
    Eur J Biochem; 1995 Oct 15; 233(2):514-9. PubMed ID: 7588796
    [Abstract] [Full Text] [Related]

  • 15. Localization of epitopes for monoclonal antibodies to urokinase-type plasminogen activator: relationship between epitope localization and effects of antibodies on molecular interactions of the enzyme.
    Petersen HH, Hansen M, Schousboe SL, Andreasen PA.
    Eur J Biochem; 2001 Aug 15; 268(16):4430-9. PubMed ID: 11502203
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Plasminogen activator inhibitor-1 detaches cells from extracellular matrices by inactivating integrins.
    Czekay RP, Aertgeerts K, Curriden SA, Loskutoff DJ.
    J Cell Biol; 2003 Mar 03; 160(5):781-91. PubMed ID: 12615913
    [Abstract] [Full Text] [Related]

  • 18. Human/chicken urokinase chimeras demonstrate sequences outside the serine protease domain that dictate autoactivation.
    Aimes RT, Regazzoni K, Quigley JP.
    Thromb Haemost; 2003 Feb 03; 89(2):382-92. PubMed ID: 12574820
    [Abstract] [Full Text] [Related]

  • 19. Structural basis for recognition of urokinase-type plasminogen activator by plasminogen activator inhibitor-1.
    Lin Z, Jiang L, Yuan C, Jensen JK, Zhang X, Luo Z, Furie BC, Furie B, Andreasen PA, Huang M.
    J Biol Chem; 2011 Mar 04; 286(9):7027-32. PubMed ID: 21199867
    [Abstract] [Full Text] [Related]

  • 20. Quantitative RT-PCR assays for the determination of urokinase-type plasminogen activator and plasminogen activator inhibitor type 1 mRNA in primary tumor tissue of breast cancer patients: comparison to antigen quantification by ELISA.
    Biermann JC, Holzscheiter L, Kotzsch M, Luther T, Kiechle-Bahat M, Sweep FC, Span PN, Schmitt M, Magdolen V.
    Int J Mol Med; 2008 Feb 04; 21(2):251-9. PubMed ID: 18204793
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.